Controller for Stability Chamber Complies with Electronic Records Requirements
Cincinnati Sub-Zero’s stability chamber controller is validated to comply with FDA guidance for electronic records and digital signatures.
Cincinnati Sub-Zero’s stability chambers and stability rooms incorporate the EZT-570S controller, which is now validated to comply with the FDA 21 CFR Part 11 guidance document for electronic records and digital signatures. The stability chambers can be used for International Council for Harmonization (ICH) Q1A pharmaceutical stability testing, shelf life testing, package testing, accelerated aging, and other tests.
The touch-screen controller simplifies chamber operation using data logging, ethernet control and monitoring from any smart phone or tablet, alarm notification via email and/or text message, data file backup, full system security, audit trail, digital signatures, and power recovery options.
Source: Cincinnati Sub-Zero
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
The Role of Forced Degradation in Method Development, Manufacturability, and CMC Strategy
April 28th 2025Forced degradation studies are critical in biologics development, particularly for monoclonal antibodies (mAbs). These studies simulate long-term environmental stressors to uncover degradation pathways and ensure the stability of critical quality attributes (CQAs), aiding in robust chemistry, manufacturing, and controls (CMC) strategies and regulatory compliance.
Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
